SCHEMBL20150396

SCHEMBL20150396

Cc1ccc(-c2ccc3c(c2)c2cc(-c4ccc(C)cc4)ccc2n3-c2ccc(C#N)cc2-c2nc(C)nc(C)n2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPKAPK2 P49137 1/20 0.37
PTGER4 P35408 1/20 0.35
PIK3CD O00329 1/20 0.34
PIK3CA P42336 1/20 0.34
ALDH1A1 P00352 1/20 0.33
CYP2A6 P11509 1/20 0.33
KDM1A O60341 1/20 0.33
GRM2 Q14416 1/20 0.33
CASP3 P42574 1/20 0.33
CHEK1 O14757 1/20 0.32
PGR P06401 1/20 0.32
CYP11B1 P15538 2/20 0.32
CYP11B2 P19099 2/20 0.32
KDM4E B2RXH2 1/20 0.32
HPGD P15428 1/20 0.32
PPARG P37231 1/20 0.32
NCOA2 Q15596 1/20 0.32
NCOA1 Q15788 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
NCOA3 Q9Y6Q9 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20150390 0.95 PTGER4 (0.42) MAPKAPK2PTGER4PIK3CDPIK3CAKDM4E
SCHEMBL20114547 0.91 MAPKAPK2 (0.37) MAPKAPK2PTGER4PIK3CDPIK3CAALDH1A1
SCHEMBL20150391 0.91 CHEK1 (0.36) MAPKAPK2PTGER4PIK3CDPIK3CAALDH1A1
SCHEMBL20114588 0.90 CYP1A2 (0.41) PTGER4ALDH1A1PGRKDM4EHPGD
SCHEMBL20655221 0.90 PIK3CD (0.36) MAPKAPK2PTGER4PIK3CDPIK3CACHEK1
SCHEMBL20150415 0.88 PTGER4 (0.36) MAPKAPK2PTGER4GRM2CHEK1KDM4E
SCHEMBL20150414 0.88 KDM4E (0.39) MAPKAPK2PTGER4ALDH1A1KDM4EHPGD
SCHEMBL20648352 0.87 PTGER4 (0.35) PTGER4PIK3CDPIK3CAALDH1A1CASP3
SCHEMBL20114559 0.86 PTGER4 (0.42) MAPKAPK2PTGER4PIK3CDPIK3CAKDM4E
SCHEMBL20114587 0.86 CHEK1 (0.40) PTGER4PIK3CDPIK3CAGRM2CASP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10421746-B2 Organic molecules, especially for use in organic optoelectronic devices CYNORA GMBH (DE) 2019-09-24 US disclosed
US-20180134686-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-05-17 US disclosed
US-20180134686-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180134686-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, EPCAM, F12 MAPKAPK2 3348/4885PTGER4 1809/4885PIK3CD 4371/4885
US-10421746-B2 Organic molecules, especially for use in organic optoelectronic devices OR10J3, EPCAM, F12 MAPKAPK2 3348/4885PTGER4 1809/4885PIK3CD 4371/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.